肠道超声可准确判断中重度溃疡性结肠炎患者的内镜下应答与缓解:一项纵向前瞻性队列研究
该前瞻性纵向队列研究纳入30例开始托法替布治疗的中重度溃疡性结肠炎患者,27例完成随访,在基线和诱导8周时行临床、生化、内镜、组织学及肠道超声评估。肠壁厚度与内镜Mayo评分、溃疡性结肠炎内镜严重指数及Robarts组织病理学指数相关,并可准确识别内镜下缓解、改善和应答。
要点
- 肠壁厚度与内镜Mayo评分(ρ=0.68,P<.0001)、溃疡性结肠炎内镜严重指数(ρ=0.73,P<.0001)及Robarts组织病理学指数(ρ=0.49,P=.002)相关。
- 乙状结肠肠壁厚度在内镜下缓解者为1.4 mm vs 未缓解者4.0 mm(P=.016)。
- 肠壁厚度识别内镜下缓解的截断值为2.8 mm(AUC 0.87),识别改善为3.9 mm(AUC 0.92),识别应答为下降32%(AUC 0.87)。
核心结论
- 肠道超声,尤其是以肠壁厚度为最重要的单一参数,在对照内镜结局评估时能高度准确地检测治疗应答。
研究设计与样本
- 前瞻性纵向队列研究,连续纳入30例开始托法替布治疗的中重度溃疡性结肠炎患者(内镜Mayo评分≥2),27例完成随访。
- 在基线和托法替布诱导8周后行临床、生化、内镜(内镜Mayo评分和溃疡性结肠炎内镜严重指数)、组织学(Robarts组织病理学指数)及肠道超声评估,评估者对其他结局设盲。
主要发现
- 肠壁厚度与内镜Mayo评分(ρ=0.68,P<.0001)、溃疡性结肠炎内镜严重指数(ρ=0.73,P<.0001)及Robarts组织病理学指数(ρ=0.49,P=.002)在两个时间点均相关。
- 乙状结肠肠壁厚度在内镜下缓解者为1.4 mm vs 未缓解者4.0 mm(P=.016);在内镜下改善者为1.8 mm vs 未改善者4.5 mm(P<.0001)。
- 肠壁厚度下降在内镜下应答者中为-58.1% vs 无应答者-13.4%(P=.018)。
- 肠壁厚度识别内镜下缓解的截断值为2.8 mm(AUC 0.87),识别改善为3.9 mm(AUC 0.92),识别应答为下降32%(AUC 0.87)。
- 黏膜下层是最具反应性的肠壁层次。
关键数值与推荐
- 内镜下缓解定义为内镜Mayo评分=0,改善定义为内镜Mayo评分≤1,应答定义为内镜Mayo评分下降≥1。
- 肠壁厚度识别内镜下缓解的截断值为2.8 mm(AUC 0.87),识别改善为3.9 mm(AUC 0.92),识别应答为下降32%(AUC 0.87)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Intestinal ultrasound (IUS) is noninvasive, cost-effective, and accurate to determine disease activity in ulcerative colitis (UC). In this study, we prospectively evaluated IUS for treatment response in a longitudinal cohort by using endoscopy and histology as gold standards. METHODS: Consecutive patients with moderate to severe UC (endoscopic Mayo score [EMS] ≥2) starting tofacitinib treatment were included. Patients were evaluated at baseline and after 8 weeks of tofacitinib induction by means of clinical, biochemical, endoscopic (EMS and UC endoscopic index for severity), histologic (Robarts Histopathologic Index) and IUS assessments. Readers of IUS, endoscopy, and histology were blinded for all other outcomes. The primary outcome was difference in bowel wall thickness (BWT) for endoscopic improvement vs no endoscopic improvement. Endoscopic remission was defined as EMS = 0, improvement as EMS ≤1, and response as a decrease of EMS ≥1. RESULTS: Thirty patients were included, with 27 patients completing follow-up. BWT correlated with EMS (ρ = 0.68, P < .0001), UC endoscopic index for severity (ρ = 0.73, P < .0001) and Robarts Histopathologic Index (ρ = 0.49, P = .002) at both time points. BWT in the sigmoid was lower in patients with endoscopic remission (1.4 mm vs 4.0 mm, P = .016), endoscopic improvement (1.8 mm vs 4.5 mm, P < .0001) and decrease in BWT was more pronounced in patients with endoscopic response (-58.1% vs -13.4%, P = .018). The most accurate cutoff values for BWT were 2.8 mm (area under the curve [AUC] 0.87) for endoscopic remission, 3.9 mm (AUC 0.92) for improvement, and decrease of 32% (AUC 0.87) for response. The submucosa was the most responsive wall layer. CONCLUSION: IUS, importantly BWT as the single most important parameter, is highly accurate to detect treatment response when evaluated against endoscopic outcomes.
引用
- de Voogd F, van Wassenaer EA, Mookhoek A, et al. Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study. Gastroenterology. 2022. PMID: 36030056. doi:10.1053/j.gastro.2022.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。